Nomura Holdings’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Nomura Holdings’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-200,000	Closed	-$928K	–	2831
2014 Q3	$928K	Buy	200,000 +2,000	+1%	+$10.7K	﹤0.01%	1477
2014 Q2	$1.31M	Buy	+198,000	New	+$1.49M	﹤0.01%	1334

Other funds holding SRNE

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Talkot Capital Sausalito, California $73.7M AUM 8.5% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Baird Milwaukee, Wisconsin $9.78B AUM 11.39% 1-Year Est. Return

CWG

C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Nomura Holdings's SRNE Position: Q4 2014 in Review

Nomura Holdings sold out of Sorrento Therapeutics, Inc. (SRNE) in Q4 2014, closing a stake of 200,000 shares — an estimated $928K sold.

Nomura Holdings first reported a position in SRNE in Q2 2014 and held it in 2 quarters. The position peaked at $1.31M in Q2 2014. 38 funds tracked by Wall St. Rank hold SRNE as of Q4 2014.

Nomura Holdings reported no remaining Sorrento Therapeutics, Inc. position as of Q4 2014 after selling out during the quarter.
Nomura Holdings sold 200,000 Sorrento Therapeutics, Inc. shares in Q4 2014, an estimated $928K.
Nomura Holdings first reported a position in Sorrento Therapeutics, Inc. in Q2 2014 and held it in 2 quarters.
Nomura Holdings's Sorrento Therapeutics, Inc. position peaked at $1.31M in Q2 2014.
38 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q4 2014.

Based on Nomura Holdings's 13F filing for Q4 2014, filed 17 Feb 2015.